Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (14) 14
life sciences & biomedicine (14) 14
science & technology (14) 14
humans (10) 10
adolescent (8) 8
adult (8) 8
young adult (8) 8
cardiovascular system & cardiology (7) 7
child (7) 7
male (7) 7
middle aged (7) 7
peripheral vascular disease (7) 7
treatment outcome (7) 7
half-life (6) 6
hemophilia (6) 6
hemophilia a - drug therapy (5) 5
hemorrhage - prevention & control (5) 5
clinical trials (4) 4
factor ix (4) 4
factor viii - adverse effects (4) 4
factor viii - therapeutic use (4) 4
haemophilia b (4) 4
hemophilia b - drug therapy (4) 4
prophylaxis (4) 4
child, preschool (3) 3
coagulants - therapeutic use (3) 3
factor ix - therapeutic use (3) 3
factor viii - pharmacokinetics (3) 3
hemorrhage - drug therapy (3) 3
infant (3) 3
original (3) 3
prothrombin complex concentrate (3) 3
recombinant proteins - administration & dosage (3) 3
recombinant proteins - therapeutic use (3) 3
von willebrand disease (3) 3
abridged index medicus (2) 2
aged (2) 2
blood coagulation factor viii (2) 2
clinical trials and observations (2) 2
coagulants - adverse effects (2) 2
coagulants - pharmacokinetics (2) 2
coagulation factors (2) 2
congenital, hereditary, and neonatal diseases and abnormalities (2) 2
dose-response relationship, drug (2) 2
factor ix - administration & dosage (2) 2
factor viii (2) 2
haemophilia a (2) 2
hematology, oncology and palliative medicine (2) 2
hemic and lymphatic diseases (2) 2
hemophilia a - blood (2) 2
hemophilia a - diagnosis (2) 2
hemostasis (2) 2
hemostatics - administration & dosage (2) 2
hemostatics - therapeutic use (2) 2
medicine (2) 2
nonacog beta pegol (2) 2
original article (2) 2
polyethylene glycols - administration & dosage (2) 2
polyethylene glycols - therapeutic use (2) 2
recombinant proteins - adverse effects (2) 2
rix-fp (2) 2
safety (2) 2
severity of illness index (2) 2
surgery (2) 2
acute phase proteins (1) 1
administration, intravenous (1) 1
albumin (1) 1
albumin fusion (1) 1
albumin fusion proteins (1) 1
antibodies - blood (1) 1
asia (1) 1
attitude (1) 1
biochemistry (1) 1
biochemistry, general (1) 1
biological products (1) 1
bleeding (1) 1
blood (1) 1
blood banks (1) 1
blood coagulation factors (1) 1
blood donation (1) 1
blood platelets - drug effects (1) 1
blood transfusion medicine (1) 1
cardiac and cardiovascular systems (1) 1
cell biology (1) 1
chemistry/food science, general (1) 1
chitin - administration & dosage (1) 1
chitin - analogs & derivatives (1) 1
chitosan (1) 1
chitosan - administration & dosage (1) 1
chitosan - analogs & derivatives (1) 1
clinical medicine (1) 1
clinical science (1) 1
clinical trial (1) 1
clinical trial, phase i (1) 1
clinical trial, phase iii (1) 1
coagulants - immunology (1) 1
coagulation (1) 1
coagulation and fibrinolysis (1) 1
confidence intervals (1) 1
consumption (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A
by Meunier, Sandrine and Alamelu, Jayanthi and Ehrenforth, Silke and Hanabusa, Hideji and Karim, Faraizah Abdul and Kavakli, Kaan and Khodaie, Melanie and Staber, Janice and Stasyshyn, Oleksandra and Yee, Donald L and Rageliene, Lina
Thrombosis and haemostasis, ISSN 0340-6245, 2017, Volume 117, Issue 9, pp. 1705 - 1713
Coagulation and Fibrinolysis | Phase III | Haemophilia A | GlycoPEGylated | Recombinant FVIII | Paediatrics | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Hemarthrosis - diagnosis | Factor VIII - pharmacokinetics | Humans | Child, Preschool | Half-Life | Infant | Male | North America | Hemarthrosis - blood | Patient Safety | Factor VIII - adverse effects | Coagulants - pharmacokinetics | Hemophilia A - diagnosis | Child | Infant, Newborn | Factor VIII - therapeutic use | Severity of Illness Index | Risk Assessment | Europe | Treatment Outcome | Hemophilia A - blood | Coagulants - therapeutic use | Asia | Coagulants - adverse effects | Hemarthrosis - prevention & control | Hemophilia A - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
by Giangrande, Paul and Abdul Karim, Faraizah and Nemes, Laszlo and You, Chur Woo and Landorph, Andrea and Geybels, Milan S and Curry, Nicola
Journal of thrombosis and haemostasis, ISSN 1538-7933, 09/2020, Volume 18, Issue S1, pp. 5 - 14
clinical trial | hemophilia A | turoctocog alfa pegol | factor VIII | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Coagulation factors | Prophylaxis | Hemophilia | Clinical trials | Safety | Factor VIII deficiency | Patients | Bleeding | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Recombinant long-acting glycoPEGylated factor IX in hemophilia B: A multinational randomized phase 3 trial
by Collins, Peter W and Young, Guy and Knobe, Karin and Karim, Faraizah Abdul and Angchaisuksiri, Pantep and Banner, Claus and Gürsel, Türkiz and Mahlangu, Johnny and Matsushita, Tadashi and Mauser-Bunschoten, Eveline P and Oldenburg, Johannes and Walsh, Christopher E and Negrier, Claude and Paradigm 2 Investigators and paradigm 2 Investigators
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 26, pp. 3880 - 3886
Life Sciences & Biomedicine | Hematology | Science & Technology | Single-Blind Method | Factor IX - administration & dosage | Humans | Middle Aged | Half-Life | Male | Treatment Outcome | Hemorrhage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Hemophilia B - drug therapy | Young Adult | Regression Analysis | Hemostasis | Adolescent | Quality of Life | Adult | Aged | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Simplifying surgery in haemophilia B: Low factor IX consumption and infrequent infusions in surgical procedures with rIX-FP
by Curtin, Julie and Santagostino, Elena and Karim, Faraizah Abdul and Li, Yanyan and Seifert, Wilfried and Négrier, Claude
Thrombosis research, ISSN 0049-3848, 04/2020, Volume 188, pp. 85 - 89
Consumption | Factor IX | Haemophilia B | rIX-FP | Surgery | Orthopaedic | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effect of the Novel Biodegradable N , O-Carboxymethylchitosan and Oligo-Chitosan on the Platelet Thrombogenicity Cascade in von Willebrand Disease
by Periayah, Mercy Halleluyah and Halim, Ahmad Sukari and Mat Saad, Arman Zaharil and Yaacob, Nik Soriani and Hussein, Abdul Rahim and Abdul Karim, Faraizah and Abdul Rashid, Ahmad Hazri and Ujang, Zanariah
Thrombosis research, ISSN 0049-3848, 2015, Volume 136, Issue 3, pp. 625 - 633
Hematology, Oncology and Palliative Medicine | Oligo-Chitosan (O-C) | Von Willebrand disease (vWD) | Platelet mechanisms | Hemostasis | N,O-Carboxymethylchitosan (NO-CMC) | VonWillebrand disease (vWD) | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | von Willebrand Diseases - blood | Humans | Middle Aged | Chitosan - administration & dosage | Drug Implants | Male | Treatment Outcome | Platelet Adhesiveness - drug effects | Young Adult | Chitin - analogs & derivatives | Hemostatics - administration & dosage | Adolescent | von Willebrand Diseases - drug therapy | Adult | Female | Platelet Activation - drug effects | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Chitosan - analogs & derivatives | Chitin - administration & dosage | Biological products | Von Willebrand factor | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model
by Tiede, Andreas and Abdul Karim, Faraizah and Jiménez-Yuste, Victor and Klamroth, Robert and Lejniece, Sandra and Suzuki, Takashi and Groth, Andreas and Santagostino, Elena
Haematologica (Roma), ISSN 0390-6078, 04/2020, p. haematol.2019.241554
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy and safety of rIX-FP in surgery: An update from a phase 3b extension study
by Pan-Petesch, Brigitte and Nagao, Azusa and Karim, Faraizah Abdul and Tosetto, Alberto and Roman, Maria Teresa Alvarez and Seifert, Wilfried and Li, Yanyan and Négrier, Claude
Thrombosis research, ISSN 0049-3848, 09/2020, Volume 193, pp. 139 - 141
Hemophilia B | Albumin fusion | Factor IX | rIX-FP | Surgery | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures
by Noordin, Siti Salmah and Noordin, Siti Salmah and Karim, Faraizah Abdul and Karim, Faraizah Abdul and Mohammad, Wan Mohd Zahiruddin bin Wan and Mohammad, Wan Mohd Zahiruddin bin Wan and Hussein, Abdul Rahim and Hussein, Abdul Rahim
Indian journal of hematology & blood transfusion, ISSN 0971-4502, 7/2018, Volume 34, Issue 3, pp. 510 - 516
Human Genetics | Coagulation factors | Temperature | Storage | Medicine & Public Health | Hematology | Fresh frozen plasma | Oncology | Blood Transfusion Medicine | Life Sciences & Biomedicine | Science & Technology | Fibrin | Medical examination | Blood coagulation factors | Blood banks | Blood | Acute phase proteins | Plasma | Laboratories | Freezing | Coagulation | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A
by Solimeno, Luigi and Lentz, Steven R and Matytsina, Irina and Zeuthen, Niels and Karim, Faraizah Abdul and Santagostino, Elena
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2304 - 2304
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Efficacy and safety of rVIII-Singlechain : Results of a phase 1/3 multicenter clinical trial in severe hemophilia A
by Mahlangu, Johnny and Kuliczkowski, Kazimierz and Karim, Faraizah Abdul and Stasyshyn, Oleksana and Kosinova, Marina V and Lepatan, Lynda Mae and Skotnicki, Aleksander and Boggio, Lisa N and Klamroth, Robert and Oldenburg, Johannes and Hellmann, Anzej and Santagostino, Elena and Baker, Ross I and Fischer, Kathelijn and Gill, Joan C and P'Ng, Stephanie and Chowdary, Pratima and Escobar, Miguel A and Khayat, Claudia Djambas and Rusen, Luminita and Bensen-Kennedy, Debra and Blackman, Nicole and Limsakun, Tharin and Veldman, Alex and Ledger, Katie St and Pabinger, Ingrid and AFFINITY Investigators and for the AFFINITY Investigators
Blood, ISSN 0006-4971, 08/2016, Volume 128, Issue 5, pp. 630 - 637
Clinical Trial, Phase III | Immunology | Hematology | Medicine(all) | Multicenter Study | Biochemistry | Clinical Trial, Phase I | Journal Article | Cell Biology | Life Sciences & Biomedicine | Science & Technology | Hemostasis - drug effects | Recombinant Proteins - therapeutic use | Demography | Factor VIII - pharmacokinetics | Humans | Middle Aged | Male | Recombinant Proteins - pharmacokinetics | Treatment Outcome | Recombinant Proteins - adverse effects | Recombinant Proteins - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Administration, Intravenous | Hemorrhage - drug therapy | Adolescent | Factor VIII - administration & dosage | Adult | Factor VIII - adverse effects | Hemophilia A - prevention & control | Hemophilia A - drug therapy | Child | Factor VIII - therapeutic use | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)
by Young, Guy and Collins, Peter W and Colberg, Torben and Chuansumrit, Ampaiwan and Hanabusa, Hideji and Lentz, Steven R and Mahlangu, Johnny and Mauser-Bunschoten, Evelien P and Négrier, Claude and Oldenburg, Johannes and Patiroglu, Turkan and Santagostino, Elena and Tehranchi, Ramin and Zak, Marek and Karim, Faraizah Abdul
Thrombosis research, ISSN 0049-3848, 2015, Volume 141, pp. 69 - 76
Hematology, Oncology and Palliative Medicine | Haemophilia B | Factor IX | Half-life | Nonacog beta pegol | Prophylaxis | Recombinant Proteins - therapeutic use | Factor IX - administration & dosage | Factor IX - therapeutic use | Humans | Middle Aged | Hemorrhage - complications | Polyethylene Glycols - adverse effects | Factor IX - adverse effects | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Hemophilia B - drug therapy | Hemostatics - adverse effects | Young Adult | Hemophilia B - complications | Hemorrhage - drug therapy | Hemostatics - administration & dosage | Adolescent | Hemophilia B - prevention & control | Adult | Aged | Hemostatics - therapeutic use | Hemophilia | Clinical trials | Prothrombin complex concentrate | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age
by Djambas Khayat, Claudia and Stasyshyn, Oleksandra and Iosava, Genadi and Ong, Jeannie B and Abdul Karim, Faraizah and Bensen-Kennedy, Debra M and St. Ledger, Katie and Limsakun, Tharin and Veldman, Alex and Pabinger, Ingrid
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3524 - 3524
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Report on von willebrand disease in Malaysia
by Periayah, Mercy Halleluyah and Halim, Ahmad Sukari and Mat Saad, Arman Zaharil and Yaacob, Nik Soriani and Karim, Faraizah Abdul
Macedonian journal of medical sciences, ISSN 1857-5749, 02/2016, Volume 4, Issue 1, pp. 112 - 117
Sociodemographic details | Laboratory profiles | Year 2011-2013 | Von willebrand disease | Malaysian report | Von Willebrand Disease | von Willebrand Disease | Clinical Science
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Knowledge and attitude towards blood donation among non blood donor residents of Kuala terengganu at Hospital Sultanah nur zahirah, Kuala Terengganu
by Noh, Sarah Mat and Karim, Faraizah Abdul and Kambali, Mohd Muhaimin and Fauzi, Hafizuddin Mohamed
Malaysian Journal of Medicine and Health Sciences, ISSN 1675-8544, 01/2019, Volume 15, pp. 53 - 62
Nondonor | Kuala Terengganu | Attitude | Knowledge | Blood donation
Journal Article
Details down arrow
15. Flow cytometric analysis of platelets mepacrine-labelled dense granules among individuals with mild bleeding symptoms
by Muhsin, Azlina and Tohit, Eusni Rahayu Mohd and Noor, Sabariah Md and Karim, Faraizah Abdul
Malaysian Journal of Medicine and Health Sciences, ISSN 1675-8544, 12/2018, Volume 14, pp. 31 - 35
Dense granules | Platelet disorders | Flowcytometric assay | Mepacrine
Journal Article
Details down arrow
16. Full Text Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B
by Kavakli, Kaan and Smith, Lynne and Kuliczkowski, Kazimierz and Korth-Bradley, Joan and You, Chur Woo and Fuiman, Joanne and Zupancic-Salek, Silva and Abdul Karim, Faraizah and Rendo, Pablo
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1523 - 1523
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Chitosan scaffold enhances growth factor release in wound healing in von Willebrand disease
by Periayah, Mercy Halleluyah and Halim, Ahmad Sukari and Mat Saad, Arman Zaharil and Yaacob, Nik Soriani and Hussein, Abdul Rahim and Karim, Faraizah Abdul and Rashid, Ahmad Hazri Abdul and Ujang, Zanariah
International journal of clinical and experimental medicine, ISSN 1940-5901, 09/2015, Volume 8, Issue 9, pp. 15611 - 15620
Von Willebrand disease | Wound healing | Chitosan | Growth factors | Platelet morphology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Identification of Novel Mutations in Exon 14 of the F8 Gene in Malaysian Patients with Severe Hemophilia A
by Moses, Emmanuel Jairaj and Moses, Emmanuel Jairaj and Ling, Sim Pei and Ling, Sim Pei and Al-Hassan, Faisal Muti and Al-Hassan, Faisal Muti and Karim, Faraizah Abdul and Karim, Faraizah Abdul and Yusoff, Narazah Mohd and Yusoff, Narazah Mohd
Indian journal of clinical biochemistry, ISSN 0970-1915, 4/2012, Volume 27, Issue 2, pp. 207 - 208
Life Sciences | Biochemistry, general | Pathology | Microbiology | Chemistry/Food Science, general | Genetic aspects | Blood coagulation factor VIII | Hemophilia | Letter to the Editor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm (TM) 4)
by Young, Guy and Collins, Peter W and Colberg, Torben and Chuansumrit, Ampaiwan and Hanabusa, Hideji and Lentz, Steven R and Mahlangu, Johnny and Mauser-Bunschoten, Evelien P and Negrier, Claude and Oldenburg, Johannes and Patiroglu, Turkan and Santagostino, Elena and Tehranchi, Ramin and Zak, Marek and Karim, Faraizah Abdul
Thrombosis research, ISSN 0049-3848, 05/2016, Volume 141, pp. 69 - 76
Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Peripheral Vascular Disease | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text 40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors
by Ljung, R and Karim, F. A and Saxena, K and Suzuki, T and Arkhammar, P and Rosholm, A and Giangrande, P and Pioneer 1 Investigators and Pioneer™1 Investigators and The Pioneer™1 Investigators
Journal of thrombosis and haemostasis, ISSN 1538-7933, 07/2013, Volume 11, Issue 7, pp. 1260 - 1268
hemophilia | inhibitors | safety | Factor VIII | Factor VII | Inhibitors | Safety | Hemophilia | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Factor VIIa - immunology | Prospective Studies | Double-Blind Method | Hemophilia A - immunology | Humans | Half-Life | Male | Treatment Outcome | Factor VIIa - adverse effects | Hemophilia A - blood | Young Adult | Adolescent | Adult | Antibodies - blood | Coagulants - pharmacokinetics | Factor VIIa - pharmacokinetics | Coagulants - adverse effects | Coagulants - immunology | Hemophilia A - diagnosis | Hemophilia A - drug therapy | Child | Clinical trials | Physicians (General practice) | Blood coagulation factor VIII | Thromboembolism | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights